Boerhaave syndrome laboratory findings: Difference between revisions
Mohamed Diab (talk | contribs) No edit summary |
Mohamed Diab (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Boerhaave syndrome}} | {{Boerhaave syndrome}} | ||
{{CMG}} {{ | {{CMG}} {{AE}} {{DM}} | ||
==Overview== | ==Overview== | ||
==Laboratory Findings== | ==Laboratory Findings== | ||
Revision as of 19:18, 28 December 2017
|
Boerhaave syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Boerhaave syndrome laboratory findings On the Web |
|
American Roentgen Ray Society Images of Boerhaave syndrome laboratory findings |
|
Risk calculators and risk factors for Boerhaave syndrome laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamed Diab, MD [2]
Overview
Laboratory Findings
Laboratory findings often are nonspecific.
Patients may present with leukocytosis. As many as 50% of patients with Boerhaave syndrome have a hematocrit value of 50% due to fluid loss into pleural spaces and tissues.
Many patients present with a pleural effusion. Thoracentesis with examination of the pleural fluid can aid in diagnosis which may contain undigested food, pH less than 6, or have an elevated amylase level.[1] [2]
References
- ↑ Attar S, Hankins JR, Suter CM, Coughlin TR, Sequeira A, McLaughlin JS (1990). "Esophageal perforation: a therapeutic challenge". Ann. Thorac. Surg. 50 (1): 45–9, discussion 50–1. PMID 2369229.
- ↑ Maher MM, Lucey BC, Boland G, Gervais DA, Mueller PR (2002). "The role of interventional radiology in the treatment of mediastinal collections caused by esophageal anastomotic leaks". AJR Am J Roentgenol. 178 (3): 649–53. doi:10.2214/ajr.178.3.1780649. PMID 11856691.